1. Home
  2. IMCC vs CPHI Comparison

IMCC vs CPHI Comparison

Compare IMCC & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IM Cannabis Corp.

IMCC

IM Cannabis Corp.

HOLD

Current Price

$1.64

Market Cap

10.4M

Sector

Health Care

ML Signal

HOLD

Logo China Pharma Holdings Inc.

CPHI

China Pharma Holdings Inc.

HOLD

Current Price

$1.69

Market Cap

9.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMCC
CPHI
Founded
1980
N/A
Country
Israel
China
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.4M
9.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IMCC
CPHI
Price
$1.64
$1.69
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
122.8K
11.5K
Earning Date
11-13-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$37,606,703.00
$4,052,266.00
Revenue This Year
$47.12
N/A
Revenue Next Year
$12.83
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.92
N/A
52 Week Low
$0.93
$1.20
52 Week High
$7.12
$3.35

Technical Indicators

Market Signals
Indicator
IMCC
CPHI
Relative Strength Index (RSI) 52.41 56.73
Support Level $1.54 $1.63
Resistance Level $1.84 $1.85
Average True Range (ATR) 0.17 0.11
MACD 0.03 0.02
Stochastic Oscillator 66.12 69.77

Price Performance

Historical Comparison
IMCC
CPHI

About IMCC IM Cannabis Corp.

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

Share on Social Networks: